Aerovate Therapeutics, Inc. (AVTE) Social Stream



Aerovate Therapeutics, Inc. (AVTE): $29.57

1.07 (+3.75%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add AVTE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#234 of 363

in industry

AEROVATE THERAPEUTICS INC (AVTE) Price Targets From Analysts

Use the tables below to see what analysts covering AEROVATE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 5 $30 $21 $24.666 $20.62 19.62%
2022-05-17 3 $24 $21 $22.666 $20.62 9.92%
2022-08-17 3 $32 $21 $25.666 $20.62 24.47%
2022-08-22 4 $32 $24 $27 $20.62 30.94%
2022-11-21 4 $27 $24 $25.333 $20.62 22.86%
2022-12-07 4 $27 $25 $26.333 $20.62 27.71%
2022-12-12 4 $54 $25 $35.333 $20.62 71.35%
2023-05-16 5 $54 $25 $35.5 $20.62 72.16%
2023-05-17 5 $50 $25 $34.5 $20.62 67.31%
2023-08-14 5 $50 $22 $33.75 $20.62 63.68%
2023-11-14 5 $48 $21 $33 $20.62 60.04%
2023-12-08 6 $48 $21 $35 $20.62 69.74%

The Trend in the Analyst Price Target


AVTE's average price target has moved up $12.33 over the prior 19 months.

AVTE reports an average of 107.28% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-16 5 54 25 35.50 19.51 81.96%
2023-05-17 5 50 25 34.50 19.46 77.29%
2023-08-14 5 50 22 33.75 14.95 125.75%
2023-08-15 5 48 22 33.25 14.78 124.97%
2023-11-14 5 48 22 33.25 14.15 134.98%

AVTE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


AVTE's average broker recommendation rating improved by 0.17 over the prior 15 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how AEROVATE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 320.76% of that group.
  • AVTE has a lower variance in analysts' estimates than -941.24% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, AEROVATE THERAPEUTICS INC's average analyst price target is higher than 1477.88% of them.
  • In terms of how AEROVATE THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 630.77% of that group.

In the Pharmaceutical Products industry, RLYB, IMRX, and RANI are the three stocks most similar to AEROVATE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding AVTE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!